P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY. (5th April 2022) - Einsele, H; Cohen, AD; Delforge, M; Hillengass, J; Goldschmidt, H; Weisel, K; Raab, M-S; Scheid, C; Schecter, JM; De Braganca, KC; Varsos, H; Yeh, T-M; et al.